Short answer
AdaptHealth Corp. (AHCO) filed an 8-K current report with the SEC on September 8, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Harriss Currie becomes CFO September 9, 2026, succeeding Jason Clemens after a one-day transition gap.
AdaptHealth Corp. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Harriss Currie becomes CFO September 9, 2026, succeeding Jason Clemens after a one-day transition gap
- $670,000 annual salary and 100% target bonus, with 2026 bonus prorated subject to continued employment
- $818,462 inducement RSU award, with half vesting over three years and half cliff-vesting after three years
- Clemens’ CFO authority ends September 8; employment terminates October 1 with contractual severance
- Qualifying Currie termination triggers 12 months’ salary continuation and potential prorated bonus and healthcare coverage
Item 7.01 · Regulation FD Disclosure
- Exhibit 99.1 furnished under Regulation FD, likely containing the substantive disclosure
- Disclosure not deemed “filed” under Exchange Act Section 18, limiting related liability exposure
- Exhibit not incorporated into other Securities Act or Exchange Act filings unless expressly referenced
Item EX-99.1 · Exhibit EX-99.1
- Harriss T. Currie appointed CFO effective September 9, 2026
- Jason Clemens transitioning out through October 1, 2026
- Currie brings over 15 years as Luminex CFO and prior healthcare finance leadership
- Leadership change targets finance oversight during AdaptHealth’s next growth phase
- Company serves approximately 4.5 million patients annually across all 50 states
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other AdaptHealth Corp. 8-K filings
Get the next AHCO 8-K as it lands
Follow AHCO for push alerts, or ask the research agent what this filing means.